Despite spending big on legal & professional consultants, FDA woes continue to haunt pharma companies

Sun Pharma ’s Halol plant received four observations three months after it received the clearance from the USFDA that had ended a two-year import ban.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news